Bio-Rad Laboratories, Inc. BIO 378.88 -18.18% NYQ · Healthcare
Open terminal

Bio-Rad Laboratories, Inc. (bio)

Unlock full data in Terminal →

BIO Dividends

Dividend yieldNot applicable
Forward P/E37.78

The figure above is this ticker’s indicated or trailing dividend yield. Yield means annual dividend divided by the current share price. A 12-month (TTM) yield uses dividends already paid; the forward yield uses the expected next year. Dividend yield meaning — then confirm the live payout for Bio-Rad Laboratories, Inc. (BIO) in Vest Terminal.

Start Free — open BIO in Vest Terminal

Access live data, filings, ownership, and analysis for Bio-Rad Laboratories, Inc..

Create free account See plans

Bio-Rad Laboratories, Inc. FAQ

What does Bio-Rad Laboratories, Inc. (BIO) do?

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The…

What is BIO's P/E ratio?

Bio-Rad Laboratories, Inc. has a trailing P/E of 46.20× based on publicly available market data.

Does BIO pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is BIO in?

Bio-Rad Laboratories, Inc. is classified in Healthcare (Medical Devices) on NYQ.

What is BIO's market capitalization?

Approximate market cap: $10.13B.

What are the main risks for BIO?

Key risks include elevated valuation, negative revenue growth, among factors on this page.

What are the strengths of BIO?

Potential positives include earnings growth of 18.7% year-over-year, gross margin of 52.0% supports competitive unit economics.

Where can I get analyst estimates for BIO?

Public analyst price targets and consensus for Bio-Rad Laboratories, Inc. are on the free /stocks/bio/estimates page. Deeper estimate history and models are available in Vest Terminal.